UK's biggest medical school looks for spin-off investors:
This article was originally published in Clinica
Executive Summary
Spinning out commercial opportunities is the aim of most academic institutions around the world. However, some probably have a greater pool of technology from which to draw. One such organisation in the UK must be Imperial College in London, which is accelerating the rate at which it spins off companies, and has reached an average of one a month. As the largest medical faculty in the UK, with nearly 700 academic staff, the university is developing a number of commercial operations in the devices and diagnostics area.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.